Increased interleukin-4 production by CD8 and γδ T cells in health-care workers is associated with the subsequent development of active tuberculosis

被引:91
作者
Ordway, DJ
Costa, L
Martins, M
Silveira, H
Amaral, L
Arroz, MJ
Ventura, FA
Dockrell, HM
机构
[1] Univ Lisbon, Inst Higiene & Med Trop, Unit Mycobacteriol, Ctr Malaria & Outras Doencas Trop, Lisbon, Portugal
[2] Hosp Egas Moniz, Lisbon, Portugal
[3] Univ Nova Lisboa, Fac Ciencias Med, P-1200 Lisbon, Portugal
[4] Comissao Nacl Luta Contra Sida, Lisbon, Portugal
[5] London Sch Hyg & Trop Med, Immunol Unit, London WC1, England
关键词
D O I
10.1086/422532
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We evaluated immune responses to Mycobacterium tuberculosis in 10 health-care workers (HCWs) and 10 non-HCWs and correlated their immune status with the development of active tuberculosis (TB). Twenty individuals were randomly recruited, tested, and monitored longitudinally for TB presentation. Peripheral blood mononuclear cells (PBMCs) from donors were stimulated with M. tuberculosis and tested for cell proliferation and the production of interferon (IFN)-gamma, interleukin (IL)-5, and IL-4, by use of enzyme-linked immunosorbent or flow-cytometric assays. HCWs had higher levels of cell proliferation ( 24,258 cpm) and IFN-gamma (6373 pg/mL) to M. tuberculosis than did non-HCWs (cell proliferation, 11,462 cpm; IFN-gamma, 3228 pg/mL). Six of 10 HCWs showed increased median percentages of CD8(+)IL-4(+) (4.7%) and gammadelta(+)IL-4(+) (2.3%) T cells and progressed to active TB. HCWs who remained healthy showed increased median percentages of CD8(+) IFN-gamma(+) (25.0%) and gammadelta+IFN-gamma(+) (8.0%) and lower percentages of CD8(+)IL-4(+) (0.05%) and gammadelta(+)IL-4(+) (0.03%) T cells.
引用
收藏
页码:756 / 766
页数:11
相关论文
共 65 条
[21]   DELAYED-TYPE HYPERSENSITIVITY, MYCOBACTERIAL VACCINES AND PROTECTIVE IMMUNITY [J].
FINE, PEM ;
STERNE, JAC ;
PONNIGHAUS, JM ;
REES, RJW .
LANCET, 1994, 344 (8932) :1245-1249
[22]   VARIATION IN PROTECTION BY BCG - IMPLICATIONS OF AND FOR HETEROLOGOUS IMMUNITY [J].
FINE, PEM .
LANCET, 1995, 346 (8986) :1339-1345
[23]   AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
CHAN, J ;
TRIEBOLD, KJ ;
DALTON, DK ;
STEWART, TA ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2249-2254
[24]   MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-RESTRICTED T-CELLS ARE REQUIRED FOR RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
GOLDSTEIN, MM ;
TRIEBOLD, KJ ;
KOLLER, B ;
BLOOM, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (24) :12013-12017
[25]   The global emergency of tuberculosis: what is the cause? [J].
Grange, JM ;
Zumla, A .
JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH, 2002, 122 (02) :78-81
[26]   Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital [J].
Hannan, MM ;
Peres, H ;
Maltez, F ;
Hayward, AC ;
Machado, J ;
Morgado, A ;
Proenca, R ;
Nelson, MR ;
Bico, J ;
Young, DB ;
Gazzard, BS .
JOURNAL OF HOSPITAL INFECTION, 2001, 47 (02) :91-97
[27]   High death rates in health care workers and teachers in Malawi [J].
Harries, AD ;
Hargreaves, NJ ;
Gausi, F ;
Kwanjana, JH ;
Salaniponi, FM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2002, 96 (01) :34-37
[28]   Tuberculosis in health care workers in Malawi [J].
Harries, AD ;
Nyirenda, TE ;
Banerjee, A ;
Boeree, MJ ;
Salaniponi, FM .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1999, 93 (01) :32-35
[29]   INTERLEUKIN-4 INHIBITS HUMAN MACROPHAGE ACTIVATION BY TUMOR-NECROSIS-FACTOR, GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR, AND INTERLEUKIN-3 FOR ANTILEISHMANIAL ACTIVITY AND OXIDATIVE BURST CAPACITY [J].
HO, JL ;
HE, SH ;
RIOS, MJC ;
WICK, EA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (02) :344-351
[30]   Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity [J].
Hoft, DF ;
Worku, S ;
Kampmann, B ;
Whalen, CC ;
Ellner, JJ ;
Hirsch, CS ;
Brown, RB ;
Larkin, R ;
Li, Q ;
Yun, H ;
Silver, RF .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (10) :1448-1457